A new therapeutic approach against melanoma
- Prosjektnummer
- SFP988-11
- Ansvarlig person
- Ugo Moens
- Institusjon
- Universitetet i Tromsø
- Prosjektkategori
- Flerårig forskningsprosjekt
- Helsekategori
- Cancer and neoplasms
- Forskningsaktivitet
- 5. Treatment Development
Homology modeling and ligand docking of Mitogen-activated protein kinase-activated protein kinase 5 (MK5).
Theor Biol Med Model 2013;10():56. Epub 2013 sep 14
PMID: 24034446
Structure and function of MK5/PRAK: the loner among the mitogen-activated protein kinase-activated protein kinases.
Biol Chem 2013 Sep;394(9):1115-32.
PMID: 23729623
Phosphorylation of heat shock protein 40 (Hsp40/DnaJB1) by mitogen-activated protein kinase-activated protein kinase 5 (MK5/PRAK).
Int J Biochem Cell Biol 2013 Dec 2;47C():29-37. Epub 2013 des 2
PMID: 24309468
Tumour promoting and suppressing roles of the atypical MAP kinase signalling pathway ERK3/4-MK5.
J Mol Signal 2012;7(1):9. Epub 2012 jul 16
PMID: 22800433
Septin 8 is an interaction partner and in vitro substrate of MK5.
World J Biol Chem 2012 May;3(5):98-109.
PMID: 22649572
Physiological roles of mitogen-activated-protein-kinase-activated p38-regulated/activated protein kinase.
World J Biol Chem 2011 May;2(5):73-89.
PMID: 21666810
: Comparative molecular dynamics simulations of mitogen-activated protein kinase-activated protein kinase 5
International Journal of Molecular Sciences; submitted
A study of the protein kinase MK5's effect on melanoma cell proliferation
Master Thesis in Medical Biology
Possible antiproliferative role of the protein kinase MK5 in tumor cells with oncogenic Ras mutations
Master Thesis in Medical Biology
A study of the protein kinase MK5’s effect on melanoma cell proliferation
masteroppgave
Possible antiproliferative role of the protein kinase MK5 in tumour cells with oncogenic Ras mutations
masteroppgave
- Inger Lindin Prosjektdeltaker
- Sergiy Kostenko Prosjektdeltaker
- Ingebrigt Sylte Prosjektdeltaker
- Sonja Eriksson Steigen Prosjektdeltaker
- Gianina Aurica Dumitriu Prosjektdeltaker
- Marijke Van Ghelue Prosjektdeltaker
- Ugo Lionel Moens Prosjektleder
eRapport er utarbeidet av Sølvi Lerfald og Reidar Thorstensen, Regionalt kompetansesenter for klinisk forskning, Helse Vest RHF, og videreutvikles av de fire RHF-ene i fellesskap, med støtte fra Helse Vest IKT
Alle henvendelser rettes til eRapport, Helse Nord